Cite
HARVARD Citation
Cummins, N. et al. (2021). Single center, open label dose escalating trial evaluating once weekly oral ixazomib in ART-suppressed, HIV positive adults and effects on HIV reservoir size in vivo.. EClinicalMedicine. p. . [Online].